Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib.
Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C.
Sudasena D, et al. Among authors: arain s.
Cardiovasc Toxicol. 2019 Aug;19(4):382-387. doi: 10.1007/s12012-018-9499-2.
Cardiovasc Toxicol. 2019.
PMID: 30543051